RNA — AVIDITY BIOSCIENCES INC

Ownership history in Aberdeen Group plc  ·  8 quarters on record

This page tracks every 13F SEC filing in which Aberdeen Group plc reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q3)
Avg. % of fund
0.01%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 304,828 +25,000 +8.9% 0.02% $13.3M —
2025 Q2 UNCHANGED 279,828 — 0% 0.01% $7.9M —
2025 Q1 ADDED 279,828 +234,916 +523.1% 0.02% $8.3M —
2024 Q4 ADDED 44,912 +20,076 +80.8% 0.00% $1.3M —
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RNA price (monthly, adj. close)

Other funds also holding RNA

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 15.62% Slotnik Capital, LLC 12.01% Twin Securities, Inc. 3Y 7Y 10.07% Sand Grove Capital Management LLP 3Y 7Y 8.11% HARVEST MANAGEMENT LLC 3Y 7Y 7.61% Slotnik Capital, LLC 6.72% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 6.39% TIG Advisors, LLC 3Y 7Y 6.02% KRYGER CAPITAL Ltd 3Y 5.82% PSquared Asset Management AG 3Y 7Y 5.68%
← Back to Aberdeen Group plc Holdings